NBIX logo

Neurocrine Biosciences, Inc. (NBIX) Total debt

Annual Total Debt:

$495.70M+$35.30M(+7.67%)
December 31, 2024

Summary

  • As of today (September 17, 2025), NBIX annual total debt is $495.70 million, with the most recent change of +$35.30 million (+7.67%) on December 31, 2024.
  • During the last 3 years, NBIX annual total debt has risen by +$38.80 million (+8.49%).
  • NBIX annual total debt is now -1.62% below its all-time high of $503.85 million, reached on December 31, 2019.

Performance

NBIX Total debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Quarterly Total Debt:

$489.80M-$3.30M(-0.67%)
June 30, 2025

Summary

  • As of today (September 17, 2025), NBIX quarterly total debt is $489.80 million, with the most recent change of -$3.30 million (-0.67%) on June 30, 2025.
  • Over the past year, NBIX quarterly total debt has increased by +$198.20 million (+67.97%).
  • NBIX quarterly total debt is now -10.44% below its all-time high of $546.90 million, reached on March 31, 2024.

Performance

NBIX Quarterly Total Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXbalance sheet metrics

Total debt Formula

Total Debt = Short Term Debt + Long Term Debt

NBIX Total debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.7%+68.0%
3 y3 years+8.5%+71.4%
5 y5 years-1.6%-4.5%

NBIX Total debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+76.8%-10.4%+79.0%
5 y5-year-1.6%+76.8%-10.4%+79.0%
alltimeall time-1.6%>+9999.0%-10.4%>+9999.0%

NBIX Total debt History

DateAnnualQuarterly
Jun 2025
-
$489.80M(-0.7%)
Mar 2025
-
$493.10M(-0.5%)
Dec 2024
$495.70M(+7.7%)
$495.70M(+73.2%)
Sep 2024
-
$286.20M(-1.9%)
Jun 2024
-
$291.60M(-46.7%)
Mar 2024
-
$546.90M(+18.8%)
Dec 2023
$460.40M(+64.3%)
$460.40M(+68.3%)
Sep 2023
-
$273.60M(-1.0%)
Jun 2023
-
$276.50M(-0.6%)
Mar 2023
-
$278.30M(-0.7%)
Dec 2022
$280.30M(-38.7%)
$280.30M(-1.0%)
Sep 2022
-
$283.10M(-0.9%)
Jun 2022
-
$285.70M(-42.5%)
Mar 2022
-
$497.10M(+8.8%)
Dec 2021
$456.90M(+8.1%)
$456.90M(+1.0%)
Sep 2021
-
$452.60M(+0.5%)
Jun 2021
-
$450.30M(+1.9%)
Mar 2021
-
$441.70M(+4.5%)
Dec 2020
$422.60M(-16.1%)
$422.60M(-18.4%)
Sep 2020
-
$517.70M(+0.9%)
Jun 2020
-
$513.00M(+0.9%)
Mar 2020
-
$508.50M(+0.9%)
Dec 2019
$503.85M(+29.7%)
$503.85M(+3.6%)
Sep 2019
-
$486.23M(+3.8%)
Jun 2019
-
$468.40M(+1.0%)
Mar 2019
-
$463.85M(+19.4%)
Dec 2018
$388.50M(+5.1%)
$388.50M(+1.3%)
Sep 2018
-
$383.65M(+1.3%)
Jun 2018
-
$378.88M(+1.2%)
Mar 2018
-
$374.21M(+1.2%)
Dec 2017
$369.62M(>+9900.0%)
$369.62M(+1.2%)
Sep 2017
-
$365.11M(+1.2%)
Jun 2017
-
$360.68M(>+9900.0%)
Mar 2017
-
$0.00(0.0%)
Dec 2016
$0.00(0.0%)
$0.00(0.0%)
Sep 2016
-
$0.00(0.0%)
Jun 2016
-
$0.00(0.0%)
Mar 2016
-
$0.00(0.0%)
Dec 2015
$0.00(0.0%)
$0.00(0.0%)
Sep 2015
-
$0.00(0.0%)
Jun 2015
-
$0.00(0.0%)
Mar 2015
-
$0.00(0.0%)
Dec 2014
$0.00(0.0%)
$0.00(0.0%)
Sep 2014
-
$0.00(0.0%)
Jun 2014
-
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
Dec 2013
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
Dec 2012
$0.00(0.0%)
$0.00(0.0%)
Sep 2012
-
$0.00(0.0%)
Jun 2012
-
$0.00(0.0%)
Mar 2012
-
$0.00(0.0%)
Dec 2011
$0.00(0.0%)
$0.00(0.0%)
Sep 2011
-
$0.00(0.0%)
Jun 2011
-
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
Dec 2010
$0.00
$0.00(0.0%)
DateAnnualQuarterly
Sep 2010
-
$0.00(0.0%)
Jun 2010
-
$0.00(0.0%)
Mar 2010
-
$0.00(0.0%)
Dec 2009
$0.00(0.0%)
$0.00(0.0%)
Sep 2009
-
$0.00(0.0%)
Jun 2009
-
$0.00(0.0%)
Mar 2009
-
$0.00(0.0%)
Dec 2008
$0.00(-100.0%)
$0.00(-100.0%)
Sep 2008
-
$109.02M(-0.3%)
Jun 2008
-
$109.35M(-0.4%)
Mar 2008
-
$109.77M(-0.4%)
Dec 2007
$110.23M(+105.5%)
$110.23M(+119.9%)
Sep 2007
-
$50.13M(-2.1%)
Jun 2007
-
$51.20M(-2.3%)
Mar 2007
-
$52.40M(-2.3%)
Dec 2006
$53.64M(-9.7%)
$53.64M(-2.5%)
Sep 2006
-
$54.99M(-2.6%)
Jun 2006
-
$56.45M(-2.6%)
Mar 2006
-
$57.95M(-2.4%)
Dec 2005
$59.40M(-10.2%)
$59.40M(-2.6%)
Sep 2005
-
$60.99M(-2.6%)
Jun 2005
-
$62.63M(-2.8%)
Mar 2005
-
$64.41M(-2.6%)
Dec 2004
$66.13M(+81.5%)
$66.13M(-3.7%)
Sep 2004
-
$68.70M(+16.7%)
Jun 2004
-
$58.88M(+24.9%)
Mar 2004
-
$47.13M(-31.6%)
Dec 2003
$36.43M(+359.1%)
$68.91M(+205.9%)
Sep 2003
-
$22.53M(+0.3%)
Jun 2003
-
$22.47M(+170.6%)
Mar 2003
-
$8.30M(+4.6%)
Dec 2002
$7.93M(+39.5%)
$7.93M(+18.6%)
Sep 2002
-
$6.69M(+19.6%)
Jun 2002
-
$5.59M(+9.3%)
Mar 2002
-
$5.12M(-10.1%)
Dec 2001
$5.69M(+47.0%)
$5.69M(+52.2%)
Sep 2001
-
$3.74M(-10.3%)
Jun 2001
-
$4.16M(+18.2%)
Mar 2001
-
$3.52M(-8.9%)
Dec 2000
$3.87M(+24.3%)
$3.87M(+26.6%)
Sep 2000
-
$3.06M(+16.1%)
Jun 2000
-
$2.63M(-8.4%)
Mar 2000
-
$2.87M(-7.7%)
Dec 1999
$3.11M(+0.8%)
$3.11M(-1.2%)
Sep 1999
-
$3.15M(-3.7%)
Jun 1999
-
$3.27M(-7.9%)
Mar 1999
-
$3.56M(+15.1%)
Dec 1998
$3.09M(+93.7%)
$3.09M(-56.3%)
Sep 1998
-
$7.07M(+57.2%)
Jun 1998
-
$4.50M(-19.3%)
Mar 1998
-
$5.57M(+248.4%)
Dec 1997
$1.59M(-2.2%)
$1.60M(>+9900.0%)
Sep 1997
-
$0.00(0.0%)
Jun 1997
-
$0.00(0.0%)
Mar 1997
-
$0.00(-100.0%)
Dec 1996
$1.63M
$1.60M(>+9900.0%)
Sep 1996
-
$0.00(0.0%)
Jun 1996
-
$0.00(-100.0%)
Mar 1996
-
$2.20M

FAQ

  • What is Neurocrine Biosciences, Inc. annual total debt?
  • What is the all time high annual total debt for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. annual total debt year-on-year change?
  • What is Neurocrine Biosciences, Inc. quarterly total debt?
  • What is the all time high quarterly total debt for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. quarterly total debt year-on-year change?

What is Neurocrine Biosciences, Inc. annual total debt?

The current annual total debt of NBIX is $495.70M

What is the all time high annual total debt for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high annual total debt is $503.85M

What is Neurocrine Biosciences, Inc. annual total debt year-on-year change?

Over the past year, NBIX annual total debt has changed by +$35.30M (+7.67%)

What is Neurocrine Biosciences, Inc. quarterly total debt?

The current quarterly total debt of NBIX is $489.80M

What is the all time high quarterly total debt for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high quarterly total debt is $546.90M

What is Neurocrine Biosciences, Inc. quarterly total debt year-on-year change?

Over the past year, NBIX quarterly total debt has changed by +$198.20M (+67.97%)
On this page